-+ 0.00%
-+ 0.00%
-+ 0.00%

GENFIT: NASHNEXT®, POWERED BY GENFIT'S NON-INVASIVE DIAGNOSTIC TECHNOLOGY NIS4®, LAUNCHED VIA LABCORP’S ONDEMAND OFFERING FOR IDENTIFICATION OF AT-RISK MASH

Reuters·06/08/2026 16:00:00

Please log in to view news